Viewing Study NCT00517218


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:59 AM
Study NCT ID: NCT00517218
Status: WITHDRAWN
Last Update Posted: 2008-02-11
First Post: 2007-08-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)
Sponsor: Genta Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module